Lv11
76 积分 2024-06-21 加入
Targeting hypoxia-inducible factors: therapeutic opportunities and challenges
23天前
已完结
Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials
1个月前
已完结
The prostate cancer drug market
2个月前
已完结
A Novel Inhalable Nanobody Targeting IL-4Rα for the Treatment of Asthma
2个月前
已完结
The recent advance of PROTACs targeting BCR-ABL for the treatment of chronic myeloid leukemia
3个月前
已完结
The non-small-cell lung cancer drug market
3个月前
已完结
BTK inhibitors: past, present, and future
4个月前
已完结
The pipeline and market for migraine drugs
5个月前
已完结
Anti-Drug Antibody Incidence Comparison of Therapeutic Proteins Administered Via Subcutaneous vs. Intravenous Route
6个月前
已完结
Claudin 18.2 as a novel therapeutic target
6个月前
已完结
皖公网安备34019202002308
